BMO Capital Cuts Amgen Price Target to $415 From $450
BMO Capital cut its price target for Amgen to $415 per share from $450.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.